Medical Affairs Reputations: Melanoma (US) 2017

Friday, November 10, 2017 General News
Email Print This Page Comment bookmark
Font : A-A+

Find out what the leading medical affairs teams are doing rightMedical affairs teams for two leading melanoma treatments are doing all the right things in the US. Not only did they earn the highest overall scores, the oncologists we surveyed gave them the highest performance and satisfaction ratings on almost every medical affairs service we asked about. This report reveals how your team measures up, so you can learn from their success and build better relationships with doctors.

NEW YORK, Nov. 9, 2017 /PRNewswire/ -- Read the full report:


what your team gets right, and where it's going wrong in Medical Affairs Reputations: Melanoma (US).Comparing 8 major melanoma treatments from Amgen, Bristol-Myers Squibb, Merck & Co., Novartis, and Roche this report reveals:

Find out what more doctors want from your medical affairs team including:

How doctors rate your team overall, and on 12 key medical affairs services.Which medical affairs services are most important, and what you can do to improve them.How, and how often doctors want to meet with your team.

That's actionable information you can use to turn your team into one that doctors rely on.

Insight into Medical Affairs Teams for These Melanoma Treatments

Cotellic (cobimetinib; Roche)Imlygic (talimogene laherparepvec; Amgen)Keytruda (pembrolizumab; Merck & Co.)Mekinist (trametinib; Novartis)Opdivo (nivolumab; Bristol-Myers Squibb)Tafinlar (dabrafenib; Novartis)Yervoy (ipilimumab; Bristol-Myers Squibb)Zelboraf (vemurafenib; Roche)

An Expert-designed Competitive View of Your Medical Affairs Team

Developed with the help of medical affairs specialists, this report gives you an in-depth comparison of 8 medical affairs teams—answering important questions like:

What do doctors need?

How, and how often are they using your medical affairs team? What services do they consider most important? How often should you contact them? What channels are best?

Does your medical affairs team deliver?

How memorable are your team's interactions with doctors? How do doctors rank your team for performance and satisfaction in 12 key areas? How does your team compare to the competition—in each area, and overall?

What needs improvement?

Are you delivering the services that are most important to doctors? Where do you need to improve? How can your team enhance its services?

Based on Interviews with Practicing Doctors

We surveyed 100 US medical oncologists and dermato-oncologists, chosen from the largest community of validated physicians in the world

All respondents:

Have been practicing for between 3 and 35 yearsSee at least 5 patients with melanoma in a typical monthDevote at least 50% of their time to direct patient careHave interacted with at least one listed product's medical affairs team in the past 6 months. 

We conducted the survey between June 1st and June 7th, 2017. 

Read the full report:

About Reportlinker ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________ Contact Clare: US: (339)-368-6001 Intl: +1 339-368-6001


View original content:

SOURCE Reportlinker


Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z


News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store